VRCA Company Profile and Key Details

Q: Who are the executives of VRCA?

Mr. Joe BonaccorsoChief Commercial OfficerMr. Ted WhitePres, Chief Executive Officer & DirectorDr. Gary Goldenberg M.D.Chief Medical OfficerMr. P. Terence KohlerChief Financial OfficerMr. Christopher G. HayesChief Legal Officer, Sec., Chief Compliance Officer & Gen. CounselMr. Eugene ScavolaExecutive Vice President of Technical OperationsDr. Bradley J. Catalone MBA, Ph.D.Head of Drug Devel.

NASDAQ : VRCA

Verrica Pharmaceuticals

$6.21

0.36+6.15%

At Close 4:00 PM

66.73

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Verrica Pharmaceuticals Inc. (VRCA) stock surged +6.15%, trading at $6.21 on NASDAQ, up from the previous close of $5.85. The stock opened at $5.96, fluctuating between $5.91 and $6.54 in the recent session.

Stock Snapshot

5.85

Prev. Close

66.15M

Market Cap

5.91

Day Low

-7.57

P/E Ratio

-0.82

EPS (TTM)

-0.85

Cash Flow per Share

5.96

Open

10.65M

Number of Shares

6.54

Day High

56.04%

Free Float in %

0.43

Book Value

62.46K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Jun 25, 2026	5.96	6.54	5.86	6.21	62.47K
Jun 24, 2026	5.66	6.12	5.66	5.85	24.15K
Jun 23, 2026	5.46	5.92	5.30	5.65	34.3K
Jun 22, 2026	5.63	6.19	5.63	5.64	105.09K
Jun 18, 2026	5.85	5.87	5.62	5.63	26.79K
Jun 17, 2026	5.98	6.11	5.83	5.83	12.42K
Jun 16, 2026	5.83	6.13	5.67	6.00	43.2K
Jun 15, 2026	5.80	6.20	5.80	5.81	31.12K
Jun 12, 2026	6.06	6.20	5.70	5.73	49.86K
Jun 11, 2026	5.83	6.22	5.60	6.03	38.22K
Jun 10, 2026	5.91	6.48	5.74	5.75	51.96K
Jun 09, 2026	6.03	6.38	5.94	6.12	33.04K
Jun 08, 2026	6.05	6.34	5.87	5.99	37.71K
Jun 05, 2026	6.30	6.80	6.00	6.04	60.53K
Jun 04, 2026	5.89	6.38	5.86	6.15	43.04K
Jun 03, 2026	5.85	6.00	5.62	5.87	24.76K
Jun 01, 2026	5.87	6.10	5.66	5.90	23.79K
May 29, 2026	5.86	6.11	5.75	5.76	35.66K
May 28, 2026	6.07	6.39	6.00	6.04	45.33K
May 27, 2026	6.09	6.49	5.93	6.06	25.89K

Contact Details

West Chester, PA 19380

United States

https://www.verrica.com 484 453 3300

About Company

Verrica Pharmaceuticals Inc. is a US-based pharmaceutical company dedicated to developing and commercializing therapeutic solutions for various skin diseases. Its primary investigational compound, VP-102, has successfully completed Phase II clinical trials for molluscum contagiosum and external genital warts, and is presently in Phase II development for common warts. Additionally, the company is advancing VP-103, a cantharidin-based product candidate, designed to treat plantar warts. Verrica maintains a strategic license and collaboration agreement with Torii Pharmaceutical Co., Ltd., focusing on the development and commercialization of its product candidates, including VP-102, for molluscum contagiosum and common warts in the Japanese market. Furthermore, a separate licensing agreement with Lytix Biopharma AS allows for the development and commercialization of LTX-315 for dermatological oncology applications. Verrica Pharmaceuticals Inc. was established in 2013 and has its headquarters in West Chester, Pennsylvania.

Stock Peers

ARGX

36.15+4.24%

argenx SE$888.65 REGN

-3.29-0.53%

Regeneron Pharmaceuticals, Inc.$620.14 UTHR

-6.51-1.18%

United Therapeutics Corporation$543.39 MDGL

4.03+0.79%

Madrigal Pharmaceuticals, Inc.$513.79 VRTX

4.98+1.05%

Vertex Pharmaceuticals Incorporated$480.18 KRYS

12.3+3.54%

Krystal Biotech, Inc.$359.93 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 PRAX

18.92+6.12%

Praxis Precision Medicines, Inc.$327.86 LGND

11.01+3.86%

Ligand Pharmaceuticals Incorporated$295.92 ALNY

-0.89-0.30%

Alnylam Pharmaceuticals, Inc.$293.17

Frequently Asked Questions

What is the current Verrica Pharmaceuticals Inc. (VRCA) stock price?

Verrica Pharmaceuticals Inc. (NASDAQ: VRCA) stock price is $6.21 in the last trading session. During the trading session, VRCA stock reached the peak price of $6.54 while $5.91 was the lowest point it dropped to. The percentage change in VRCA stock occurred in the recent session was 6.15% while the dollar amount for the price change in VRCA stock was $0.36.

VRCA's industry and sector of operation?

The NASDAQ listed VRCA is part of Biotechnology industry that operates in the broader Healthcare sector. Verrica Pharmaceuticals Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of VRCA?

Mr. Joe Bonaccorso
Chief Commercial Officer
Mr. Ted White
Pres, Chief Executive Officer & Director
Dr. Gary Goldenberg M.D.
Chief Medical Officer
Mr. P. Terence Kohler
Chief Financial Officer
Mr. Christopher G. Hayes
Chief Legal Officer, Sec., Chief Compliance Officer & Gen. Counsel
Mr. Eugene Scavola
Executive Vice President of Technical Operations
Dr. Bradley J. Catalone MBA, Ph.D.
Head of Drug Devel.

How VRCA did perform over past 52-week?

VRCA's closing price is 89.33% higher than its 52-week low of $3.28 where as its distance from 52-week high of $9.82 is -36.77%.

How many employees does VRCA have?

Number of VRCA employees currently stands at 71.

Link for VRCA official website?

Official Website of VRCA is: https://www.verrica.com

How do I contact VRCA?

VRCA could be contacted at phone 484 453 3300 and can also be accessed through its website. VRCA operates from 44 West Gay Street, West Chester, PA 19380, United States.

How many shares of VRCA are traded daily?

VRCA stock volume for the day was 62.46K shares. The average number of VRCA shares traded daily for last 3 months was 71.41K.

What is the market cap of VRCA currently?

The market value of VRCA currently stands at $66.15M with its latest stock price at $6.21 and 10.65M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	71
Beta	1.49
Sales or Revenue	$5.12M
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	71
Beta	1.49
Sales or Revenue	$5.12M
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

VRCA Company Profile and Key Details

Verrica Pharmaceuticals

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Dividend & Fair Value

Company Overview

Key Takeaways

Price Forecast & Outlook

Valuation Metrics